Literature DB >> 65455

Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier.

K Eickhoff, J Wikström, S Poser, H Bauer.   

Abstract

The leucocyte count, total protein, albumin, IgG, IgA and IgM content of the cerebrospinal fluid (CSF) of 103 multiple sclerosis (MS) patients was determined. In 54 cases a simultaneous analysis of serum was also carried out. As a sign of an intact blood brain barrier the albumin concentration was normal in 76.7%. Taking into account the relative IgG quotient in CSF and serum, and the albumin and IgG concentration gradients between CSF and serum, it was possible to reveal an elevation of IgG content in CSF of MS patients in 75 and 83%, respectively. Without a simultaneous analysis of serum this was the case only in 51.5%. In MS cases with an intact blood brain barrier the values for IgA and/or IgM were slightly elevated in 11.7%. This study demonstrates analytic methods, which support the hypothesis of IgG synthesis by cells accumulating within the CNS in MS. A correlation of the laboratory results and clinical manifestation of MS was tried.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65455     DOI: 10.1007/BF00316151

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  [Exchange processes between plasma and cerebrospinal fluid examined with radio-iodine labeled albumin].

Authors:  E FRICK; L SCHEID-SEYDEL
Journal:  Klin Wochenschr       Date:  1958-01-15

2.  Clinical data from 418 MS patients in relation to the diagnosis. First experiences with an optical mark reader documentation system.

Authors:  S Poser; H Hauptvogel
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

3.  Immunoglobulin synthesis within the central nervous system in disseminated sclerosis.

Authors:  S Cohen; R Bannister
Journal:  Lancet       Date:  1967-02-08       Impact factor: 79.321

4.  Multiple sclerosis: brain immunoglobulin-G and albumin.

Authors:  W W Tourtellotte; J A Parker
Journal:  Nature       Date:  1967-05-13       Impact factor: 49.962

5.  The immunogenesis of the multiple sclerosis plaque.

Authors:  C E Lumsden
Journal:  Brain Res       Date:  1971-05-21       Impact factor: 3.252

Review 6.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

7.  Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation.

Authors:  K Ganrot; C B Laurell
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

8.  [Immunochemical estimation of IgG and albumin in cerebrospinal fluid].

Authors:  B Delpech; E Lichtblau
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

9.  Albumin exchange between plasma and cerebrospinal fluid.

Authors:  R W Cutler; R K Deuel; C F Barlow
Journal:  Arch Neurol       Date:  1967-09

10.  Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain.

Authors:  W W Tourtellotte; J A Parker
Journal:  Science       Date:  1966-11-25       Impact factor: 47.728

View more
  8 in total

1.  Protein pattern of cerebrospinal fluid in various neurological diseases.

Authors:  C R Hornig; O Busse; W Dorndorf
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

2.  Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.

Authors:  O Christensen; J Clausen; T Fog
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

3.  Differentiation of the humoral immune response in inflammatory diseases of the central nervous system.

Authors:  K Felgenhauer
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

4.  Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.

Authors:  B Rocchelli; M Poloni; P Mazzarello; G Piccolo; M Delodovici; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-07

5.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

6.  Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system.

Authors:  K Kitz; H Lassmann; D Karcher; A Lowenthal
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 7.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

8.  Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction.

Authors:  Daji Wang; Hongxia Duan; Jing Feng; Jianquan Xiang; Liqun Feng; Dan Liu; Xuehui Chen; Lin Jing; Zheng Liu; Dexi Zhang; Hongjun Hao; Xiyun Yan
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.